Clinical Trials Logo

High-grade Osteosarcoma clinical trials

View clinical trials related to High-grade Osteosarcoma.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04359550 Not yet recruiting - Clinical trials for High-grade Osteosarcoma

Study of ZKAB001 for Maintenance Therapy in Patients With High-grade Osteosarcoma After Adjuvant Chemotherapy

Start date: June 1, 2020
Phase: Phase 3
Study type: Interventional

It is a randomized, double-blind, placebo-controlled, multicenter study with the sample size is 362. The patients with high-grade osteosarcoma who had previously received surgery and completed adjuvant chemotherapy will be randomly assigned to ZKAB001 group (trial group) or placebo group (control group) according to 1:1. The purpose is to evaluate the efficacy and safety of ZKAB001 in maintenance therapy after adjuvant chemotherapy in patients with high-grade osteosarcoma.